News

FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...
MedPage Today4d
Some ADHD Meds Can Cause Significant Weight Loss in Young Kids, FDA Warns
Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...
US FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
US FDA to revise label of ADHD stimulants to add weight loss risk in patients younger than 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...
MPR3d
FDA: Weight Loss Risk in Younger ADHD Patients on Extended-Release Stimulants
Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...
Becker's Hospital Review5d
FDA revises ADHD medication label to note weight loss risk
The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...
clinicaladvisor.com3d
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
Close more info about FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk Loading... You’ve read {{metering-count}} of {{metering-total}} articles this month.
KSL5d
FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...